Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaked Lev-Ari

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Integrative Cancer Therapies|September 3, 2024
Targeting the Gut Microbiome to Improve Immunotherapy Outcomes: A ReviewAdi David, Shaked Lev-Ari
Harefuah|July 24, 2025
[THERAPY IN PATIENTS AFFECTED BY BREAST AND PROSTATE CANCER]Adi David, Sharon Eilon, Shaked Lev-Ari, et al.
Harefuah|November 21, 2024
[CANCER SURVIVORS - QUESTIONS, CONSIDERATIONS AND POSSIBLE SOLUTIONS]Adi David, David Hausner, Roni Burshtein, et al.
Cancers|August 23, 2020
Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic MelanomaNethanel Asher, Guy Ben-Betzalel, Shaked Lev-Ari, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2022
The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring SteroidsNeil J Shah, Michael R Cook, Tianmin Wu, et al.
Journal for Immunotherapy of Cancer|May 15, 2021
Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapyAbraham Nissani, Shaked Lev-Ari, Tomer Meirson, et al.
JAMIA Open|July 10, 2025
Utilizing Immuno-Oncology registry data for enhanced non-small cell lung cancer treatment predictionsYili Zhang, Shaked Lev-Ari, Jacob Zaemes, et al.
Cancer|March 23, 2023
The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective studyShaked Lev-Ari, Michael Serzan, Tianmin Wu, et al.
Cancers|June 27, 2024
Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical TrialsNeil J Shah, Alexandra Della Pia, Tianmin Wu, et al.
Cancer Medicine|November 2, 2025
Associations Between Anxiety or Depression Diagnosis and Immune Checkpoint Inhibitor OutcomesHeather Derry-Vick, Neil J Shah, Jaeil Ahn, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Integrative Cancer Therapies|September 3, 2024
Targeting the Gut Microbiome to Improve Immunotherapy Outcomes: A ReviewAdi David, Shaked Lev-Ari
Harefuah|July 24, 2025
[THERAPY IN PATIENTS AFFECTED BY BREAST AND PROSTATE CANCER]Adi David, Sharon Eilon, Shaked Lev-Ari, et al.
Harefuah|November 21, 2024
[CANCER SURVIVORS - QUESTIONS, CONSIDERATIONS AND POSSIBLE SOLUTIONS]Adi David, David Hausner, Roni Burshtein, et al.
Cancers|August 23, 2020
Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic MelanomaNethanel Asher, Guy Ben-Betzalel, Shaked Lev-Ari, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2022
The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring SteroidsNeil J Shah, Michael R Cook, Tianmin Wu, et al.
Journal for Immunotherapy of Cancer|May 15, 2021
Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapyAbraham Nissani, Shaked Lev-Ari, Tomer Meirson, et al.
JAMIA Open|July 10, 2025
Utilizing Immuno-Oncology registry data for enhanced non-small cell lung cancer treatment predictionsYili Zhang, Shaked Lev-Ari, Jacob Zaemes, et al.
Cancer|March 23, 2023
The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective studyShaked Lev-Ari, Michael Serzan, Tianmin Wu, et al.
Cancers|June 27, 2024
Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical TrialsNeil J Shah, Alexandra Della Pia, Tianmin Wu, et al.
Cancer Medicine|November 2, 2025
Associations Between Anxiety or Depression Diagnosis and Immune Checkpoint Inhibitor OutcomesHeather Derry-Vick, Neil J Shah, Jaeil Ahn, et al.
Pageof 1